Displaying 21–30 of 218 research results
Oct 18, 2021
The emerging gene therapy is being designed to more safely reach the fovea
Oct 8, 2021
Emerging dual-vector gene therapies to address current cargo-size limitations were highlighted during the meeting.
Sep 30, 2021
The emerging treatment targets a specific mutation (c.2991+1655A>G in Intron 26) of the gene CEP290 which causes Leber congenital amaurosis 10 (LCA 10)
Sep 28, 2021
First two programs are for Leber congenital amaurosis: LCA5-lebercillin and LCA13-RDH12
Sep 27, 2021
Current research portfolio is comprised of nearly 100 projects at prominent institutions around the world
Sep 24, 2021
Visit www.LUMEOSstudy.com for more information about trial
Sep 10, 2021
Known as APL-2, the drug met its primary endpoint in the OAKS clinical trial but not the DERBY trial
Sep 9, 2021
Early, encouraging results from two human studies — trials launched by Bionic Sight and GenSight — are putting optogenetic therapies in the spotlight for patients with advanced vision loss from retinal conditions.
Jul 19, 2021
While the trial is for people with RP, the company hopes it will also benefit people with other retinal degenerative diseases
Jun 25, 2021
The company is planning a late-stage trial for its achromatopsia (CNGB3) gene therapy.